Inactive Instrument
CUSPIS CAP L Stock Toronto S.E.
Stocks
CUSP.P
CA23168X1078
Specialty Chemicals
OTC Markets Traded| Market Cap | 276M 193M 169M 156M 143M 270M 18.58B 1.86B 731M 9.1B 724M 709M 31.32B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 276M 193M 169M 156M 143M 270M 18.58B 1.86B 731M 9.1B 724M 709M 31.32B | EV / Sales 2026 * |
98.7x | EV / Sales 2027 * | 3.78x |
| Free-Float |
86.06% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +14.14% |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Nicol
CEO | Chief Executive Officer | 51 | 2016-08-09 |
Joshua George
DFI | Director of Finance/CFO | - | 2024-04-07 |
Stuart Watson
PRN | Corporate Officer/Principal | - | 2026-04-21 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Nicol
BRD | Director/Board Member | 51 | 2016-08-09 |
Robert Galyen
BRD | Director/Board Member | - | 2023-06-30 |
Jack Perkowski
CHM | Chairman | 76 | 2023-10-23 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +14.14% | +41.25% | - | - | 193M | ||
| -4.40% | -21.72% | +83.57% | +13.72% | 5.16B | ||
| -2.58% | -1.94% | -31.25% | -47.80% | 2.3B | ||
| -5.48% | -8.89% | +29.71% | +121.78% | 1.03B | ||
| -10.59% | -28.60% | +71.00% | +85.63% | 777M | ||
| +5.30% | +9.38% | +28.70% | +8.93% | 627M | ||
| +2.84% | +7.41% | -20.29% | -50.61% | 578M | ||
| -4.20% | -3.12% | -23.53% | -13.60% | 279M | ||
| -4.45% | -4.25% | -46.31% | -0.88% | 226M | ||
| +0.69% | -1.35% | -49.13% | -52.90% | 189M | ||
| Average | -0.87% | -2.27% | +4.72% | +7.14% | 1.24B | |
| Weighted average by Cap. | -3.25% | -7.25% | +38.06% | +10.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.8M 1.96M 1.71M 1.58M 1.45M 2.74M 188M 18.85M 7.41M 92.21M 7.34M 7.18M 317M | 73M 50.97M 44.55M 41.11M 37.89M 71.41M 4.91B 491M 193M 2.4B 191M 187M 8.28B |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Specialty Chemicals
















